WO2005084205A3 - Diamino thiazoloindan derivatives and their use - Google Patents
Diamino thiazoloindan derivatives and their use Download PDFInfo
- Publication number
- WO2005084205A3 WO2005084205A3 PCT/US2005/005921 US2005005921W WO2005084205A3 WO 2005084205 A3 WO2005084205 A3 WO 2005084205A3 US 2005005921 W US2005005921 W US 2005005921W WO 2005084205 A3 WO2005084205 A3 WO 2005084205A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- aralkyl
- alkynyl
- ring
- line drawn
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
- C07C211/60—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton containing a ring other than a six-membered aromatic ring forming part of at least one of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/14—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/41—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78942104A | 2004-02-27 | 2004-02-27 | |
US10/789,421 | 2004-02-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005084205A2 WO2005084205A2 (en) | 2005-09-15 |
WO2005084205A3 true WO2005084205A3 (en) | 2005-10-20 |
Family
ID=34919709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/005921 WO2005084205A2 (en) | 2004-02-27 | 2005-02-25 | Diamino thiazoloindan derivatives and their use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005084205A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ564130A (en) * | 2005-06-02 | 2009-12-24 | Jenrin Discovery | N-propargyl-1-aminoindan compounds useful for treating obesity |
SA109300120B1 (en) * | 2008-02-21 | 2011-10-08 | استرازينيكا ايه بي | Compound (R) -N*6*-Ethyl-6, 7-Dihydro-5H-Indeno (5,6- D) Thiazole-2, 6-Diamine and the Use as Antipsychotics |
US8809526B2 (en) * | 2010-07-19 | 2014-08-19 | Onyx Pharmaceuticals, Inc. | Synthesis of cyclopentaquinazolines |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291494B1 (en) * | 1998-07-01 | 2001-09-18 | Wikstroem Haakan Vilhelm | 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
-
2005
- 2005-02-25 WO PCT/US2005/005921 patent/WO2005084205A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291494B1 (en) * | 1998-07-01 | 2001-09-18 | Wikstroem Haakan Vilhelm | 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
Also Published As
Publication number | Publication date |
---|---|
WO2005084205A2 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200508180A (en) | Therapeutic agents | |
MX2007007220A (en) | Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders. | |
WO2004087699A3 (en) | Thiazoles useful as inhibitors of protein kinases | |
WO2004087698A3 (en) | Thiazoles useful as inhibitors of protein kinases | |
WO2004013120A8 (en) | Novel benzodioxoles | |
SE0104334D0 (en) | Therapeutic agents | |
MY156747A (en) | Isoxazolo-pyridine derivatives | |
HUP0002843A2 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
HK1070063A1 (en) | Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments | |
WO2007062999A3 (en) | 1,5-substituted indol-2-yl amide derivatives | |
PT1159279E (en) | 4-OXO-4,7-DIHYDROTIENE-2,3-B | PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS | |
CA2279620A1 (en) | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) | |
ATE457988T1 (en) | A2A ADENOSINE RECEPTOR ANTAGONISTS | |
AU2006294633A8 (en) | 7-[2-[4- (6-fluoro-3-methyl -1,2-benzisoxazol-5-yl) -1-piperazinyl]ethyl] -2- ( 1-propynyl) -7h-pyrazolo- [ 4,3-e]-[1,2,4] -triazolo- [1,5-c] -pyrimidin- 5 amine | |
WO2005075450A3 (en) | Spiro-benzodioxoles and their use as cb1 antagonists | |
JP2005511697A5 (en) | ||
IL160045A0 (en) | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues | |
HUP0400743A2 (en) | Imidazo[1,5-a]pyrimido[5,4-d]benzazepine derivatives, process for their preparation and pharmaceutical conpositions containing them | |
MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
HK1027809A1 (en) | 4-tetrahydropyridylpyrimidine derivative | |
TW200719894A (en) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives | |
MX2020013896A (en) | Manufacturing process and intermediates for a pyrrolo[2,3- d]pyrimidine compound and use thereof. | |
TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
WO2007100583A3 (en) | Propargylated aminoindans, processes for preparation, and uses thereof | |
MXPA05005790A (en) | Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase |